Adaptive designs for dual-agent phase I dose-escalation studies. (2013)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nrclinonc.2013.35
PubMed Identifier: 23507740
Publication URI: http://europepmc.org/abstract/MED/23507740
Type: Journal Article/Review
Volume: 10
Parent Publication: Nature reviews. Clinical oncology
Issue: 5
ISSN: 1759-4774